New Phase I/II Trial for Myelodysplastic Syndrome, Acute Myeloid Leukemia, and Multiple Myeloma is Now Underway!
The very first patient in Medigene AG's clinical trial examining MDG1011 has officially received the treatment. This is the company's first human clinical trial for this TCR therapy. The trial…